Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Survey Provides Deep Dive into Deep Infiltrative Endometriosis

June 12, 2020

Deep infiltrative endometriosis (DIE) impacts more than half of Health Union's "Endometriosis In America" survey respondents.

People are concerned about returning back to normal during COVID-19.

COVID-19 Resource Center for Pharma Marketers

June 5, 2020

Browse through data-driven COVID-19 resources for pharma marketing to see how the pandemic is affecting people living with chronic health conditions.

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

June 3, 2020

Although frustrated by COVID-19's physical and mental toll, people with chronic conditions approach the idea of “returning to normal” with concern.

Asthma Patient-Reported Survey Data | 2020

June 3, 2020

40% of people with asthma experience symptoms at least once a day, according to Health Union survey data from its online health community.

Let’s Talk About Sex: Why Treating Intimacy As a Clinical Symptom Matters

February 5, 2021

Findings from Health Union’s In America surveys show sex and intimacy can be greatly impacted by a person’s condition, including symptoms and side effects.

The Year of Substance: Finding Success During 2020 and Beyond

January 22, 2021

For Health Union in 2020, substance can be attributed to our mission and core values, a strong people-first culture and the ability to adapt.

5 Ways to Make Your Pharma Marketing More Personal

January 20, 2021

Break through the noise and reach and engage people during their unique health journey with our tips to help personalize your pharma marketing strategies.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Healthcare Industry Thought Leadership

Contact